Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel constrained CCK-B dipeptoid antagonists derived from pipecolic acid

B Bellier1, S Da Nascimento, H Meudal

  • 1Département de Pharmacochimie Moléculaire et Structurale, INSERM U266, CNRS URA D1500, UFR des Sciences Pharmaceutiques et Biologiques, Paris, France.

Bioorganic & Medicinal Chemistry Letters
|January 1, 1999
PubMed
Summary

Researchers synthesized novel pipecolic acid derivatives for dipeptoid incorporation. These compounds act as cholecystokinin-B receptor antagonists, offering insights into conformational needs for receptor binding.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The regulatory dendritic cell marker C1q is a potent inhibitor of allergic inflammation.

Mucosal immunology·2016
Same author

Tetraspanins displayed in retrovirus-derived virus-like particles and their immunogenicity.

Vaccine·2016
Same author

Skin decontamination of mustards and organophosphates: comparative efficiency of RSDL and Fuller's earth in domestic swine.

Human & experimental toxicology·2007
Same author

Protection against soman-induced neuropathology and respiratory failure: a comparison of the efficacy of diazepam and avizafone in guinea pig.

Toxicology·2006
Same author

Peripheral ChE inhibition modulates brain monoamines levels and c-fos oncogene in mice subjected to a stress situation.

Neurochemical research·2005
Same author

Induction of acute lung injury after intranasal administration of toxin botulinum a complex.

Toxicologic pathology·2005

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Organic Synthesis

Background:

  • The cholecystokinin-B receptor (CCK-B) is a G protein-coupled receptor implicated in various physiological processes.
  • CCK-B receptor antagonists are of therapeutic interest for conditions such as anxiety and gastrointestinal disorders.
  • Understanding the structural basis for CCK-B receptor antagonism is crucial for developing effective drugs.

Purpose of the Study:

  • To synthesize and characterize novel 4-substituted pipecolic acid derivatives.
  • To incorporate these derivatives into dipeptoid structures.
  • To evaluate the potential of these novel compounds as CCK-B receptor antagonists and elucidate conformational requirements for receptor binding.

Main Methods:

  • Synthesis of 4-substituted pipecolic acid derivatives via established organic chemistry protocols.

Related Experiment Videos

  • Incorporation of synthesized derivatives into dipeptoid scaffolds.
  • Pharmacological evaluation of synthesized dipeptoids for CCK-B receptor antagonist activity.
  • Conformational analysis and comparison with related structures.

    • Main Results:

    • A series of novel 4-substituted pipecolic acid derivatives were successfully synthesized and incorporated into dipeptoids.
    • The resulting dipeptoids demonstrated moderate potency as CCK-B receptor antagonists.
    • Structural analysis provided valuable information regarding the conformational preferences necessary for effective CCK-B receptor antagonism.

    Conclusions:

    • The synthesized pipecolic acid-based dipeptoids represent a promising class of CCK-B receptor antagonists.
    • The study highlights the importance of specific conformations for optimal CCK-B receptor recognition.
    • These findings contribute to the structure-activity relationship understanding for CCK-B receptor antagonists.